Eden Innovations (EDE) AI Stock Analysis

• Market Cap: AU$66.12M
• Dividend Yield: N/A
• Average Volume (3M): 1.01M
• Price to Earnings (P/E): ―
• Beta (1Y): 1.00
• Revenue Growth: 20.65%
• EPS Growth: 15.54%
• Country: AU
• Employees: 35
• Sector: Industrials
• Sector Strength: 72
• Industry: Industrial - Machinery
• EPS (TTM): -0.02
• Shares Outstanding: 550,625,000
• 10 Day Avg. Volume: 807,653
• 30 Day Avg. Volume: 1,006,652
• PEG Ratio: >-0.01
• Price to Book (P/B): -4.66
• Price to Sales (P/S): 3.35
• P/FCF Ratio: -2.20
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 44 Neutral
• Price Target: AU$0.12 ▲(202.50% Upside)

The score is driven primarily by very weak financial performance, including severe losses, declining revenue, negative equity, and negative cash flows. Technicals provide a partial offset with an uptrend and positive MACD, but the elevated RSI suggests the move may be overextended. Valuation is constrained by ongoing losses (negative P/E) and no dividend yield data.

Positive Factors

High gross profit margin

A 68.95% gross margin reflects strong product-level economics and pricing power that persist beyond short-term cycles. This structural margin provides a cushion against revenue volatility and, if management reduces fixed overhead, creates a credible pathway to restore operating profitability over a multi‑month recovery.

Lean workforce

A small headcount (35 employees) implies a lean operating base and lower fixed personnel costs, enabling quicker cost adjustments and nimble execution. Over a 2–6 month horizon this structural agility helps preserve cash, accelerates decision cycles and supports margin improvement as revenues stabilize or recover.

Free cash flow aligns with reported losses

A free cash flow to net income ratio of 1.0 indicates reported losses are translating into cash outflows at a similar magnitude, suggesting fewer large non‑cash charges. This alignment aids realistic cash planning and means management can directly influence cash burn through operational cuts or working‑capital actions in the medium term.

Negative Factors

Negative shareholders' equity

Negative equity of -A$1.75m and an effective debt-to-equity of -9.35 signal capital impairment and elevated leverage. This structural balance‑sheet weakness constrains access to financing, raises refinancing and covenant risk, and limits the company’s ability to invest or absorb shocks over the coming months.

Severe revenue decline

A 154.5% year‑over‑year revenue decline denotes a material loss of sales and market traction that is not transient. Restoring top line requires product, market or commercial changes; absent that, fixed costs will continue to damage margins and cash flow, making a sustainable recovery difficult in the 2–6 month horizon.

Deep losses and negative cash generation

Net margin of -284.77% together with negative operating and free cash flow indicate persistent unprofitable operations and ongoing cash burn. These are durable operational problems that require structural changes (cost base reduction, revenue rebuild or external capital); otherwise liquidity and solvency pressures will intensify.

Eden Innovations Business Overview & Revenue Model

Company Description

Eden Innovations (EDE) is an innovative company focused on providing advanced solutions in the field of clean energy and sustainable technologies. Primarily operating in the sectors of hydrogen generation and carbon capture, Eden Innovations specializes in developing technologies that enhance energy efficiency and reduce carbon emissions. Their core products include proprietary hydrogen production systems and carbon-reduction solutions designed for industrial use, aiming to support industries in transitioning to more sustainable practices.

How the Company Makes Money

Eden Innovations generates revenue through multiple streams, including the sale of its hydrogen production systems and carbon capture technologies to various industries such as energy, manufacturing, and transportation. The company also earns income from licensing its proprietary technology to other firms, enabling them to implement Eden's solutions within their operations. Additionally, Eden Innovations may engage in strategic partnerships with energy companies and government agencies, which can provide funding, grants, or contracts for research and development projects. These collaborations not only enhance the company's visibility in the market but also contribute to a stable revenue base as they expand their footprint in the clean energy sector.

Eden Innovations Financial Statement Overview

Summary

Financials are highly distressed: steep revenue decline, very large negative net margin (-284.77%), and negative EBIT/EBITDA margins. Balance sheet risk is elevated with negative equity (-1.75M) and problematic leverage signals, while operating and free cash flow are also negative, indicating weak underlying cash generation.

Income Statement

Eden Innovations has faced significant challenges in its income statement metrics. The company has consistently reported negative net income, with a net profit margin of -284.77% in the most recent year. Revenue has declined by 154.5% compared to the previous year, indicating a severe downturn. Gross profit margin remains positive at 68.95%, but the negative EBIT and EBITDA margins highlight operational inefficiencies and financial distress.

Balance Sheet

The balance sheet reveals a precarious financial position with a negative stockholders' equity of -1.75 million, resulting in a concerning debt-to-equity ratio of -9.35. This indicates high financial leverage and potential solvency issues. The return on equity is positive at 396.26%, but this is due to the negative equity, which distorts the metric. Overall, the balance sheet suggests significant financial instability.

Cash Flow

Cash flow analysis shows negative operating cash flow and free cash flow, with a free cash flow to net income ratio of 1.0, indicating that cash outflows are closely aligned with net losses. The operating cash flow to net income ratio is -0.19, reflecting poor cash generation relative to net losses. The company has experienced a decline in free cash flow growth, further stressing its cash flow position.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	1.89M	2.43M	2.02M	4.70M	4.15M	3.28M
Gross Profit	1.28M	1.68M	1.39M	-2.17M	-3.36M	-3.10M
EBITDA	-3.01M	-3.93M	-4.83M	-15.08M	-4.49M	-3.73M
Net Income	-5.17M	-6.93M	-7.55M	-17.87M	-6.65M	-5.76M
Balance Sheet
Total Assets	17.84M	17.84M	19.07M	17.00M	25.79M	24.48M
Cash, Cash Equivalents and Short-Term Investments	561.18K	561.18K	975.20K	2.53M	1.55M	2.18M
Total Debt	16.34M	16.34M	12.79M	10.21M	4.91M	5.26M
Total Liabilities	19.59M	19.59M	15.10M	12.28M	6.30M	6.34M
Stockholders Equity	-1.75M	-1.75M	3.98M	4.73M	19.49M	18.14M
Cash Flow
Free Cash Flow	-2.84M	-3.70M	-5.27M	-5.11M	-7.51M	-7.46M
Operating Cash Flow	-2.84M	-3.70M	-5.22M	-4.17M	-6.03M	-5.55M
Investing Cash Flow	-305.20K	-305.20K	-586.79K	-940.93K	-1.48M	-1.91M
Financing Cash Flow	3.59M	3.59M	4.26M	6.09M	6.78M	8.45M

Eden Innovations Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
WWG	74 Outperform	AU$55.95M	12.40	20.77%	4.55%	66.80%	625.00%
Sector *	63 Neutral	$10.79B	15.43	7.44%	2.01%	2.89%	-14.66%
SSH	57 Neutral	AU$19.62M	22.50	6.19%	―	-6.52%	-20.79%
AQN	50 Neutral	AU$41.86M	-9.90	-28.36%	―	12.74%	-392.59%
EDE	44 Neutral	AU$66.12M	-3.68	-664.09%	―	20.65%	15.54%
ECT	42 Neutral	AU$52.01M	-5.95	-164.39%	―	―	15.66%

Eden Innovations Corporate Events

Eden Innovations Cuts Debt and Ramps Up Global Sales of EdenCrete and OptiBlend

Eden Innovations has completed a major recapitalisation and debt refinancing, raising A$4.35 million through a placement and cutting total debt by about A$16 million via loan repayments, refinancing of high-interest borrowings, and conversion of shareholder loans, materially strengthening its balance sheet and financial flexibility. Operationally, the quarter saw growing commercial traction for its EdenCrete Pz7 admixture, including Holcim Ecuador’s largest order to date taking cumulative purchases above A$1 million and ongoing US projects, as well as promising Indian highway trials that could unlock a significant infrastructure market, while OptiBlend orders in the US—particularly from data centres—accelerated sharply, with recent order intake already approaching last year’s full OptiBlend sales and a substantial pipeline of quotations and purchase orders underpinning near-term revenue visibility.

The most recent analyst rating on (AU:EDE) stock is a Hold with a A$0.07 price target. To see the full list of analyst forecasts on Eden Innovations stock, see the AU:EDE Stock Forecast page.

Eden Innovations Targets Indian Highway Market With New EdenCrete Pz7 Trials

Eden Innovations has begun larger-scale trials of its EdenCrete Pz7 concrete admixture in India in collaboration with the government’s Central Road Research Institute, targeting two widely used concrete grades (M60 and M40 PQC) employed in major infrastructure works. The testing aims to enhance flexural strength and abrasion resistance in concrete used for bridge overlays, ultra-thin white topping and new pavements, potentially helping address India’s recent issues with premature highway pavement failures and aligning with the government’s shift toward higher-quality, more sustainable construction methods; if successful, the trials could significantly boost Eden’s Indian sales and open a sizeable market, including anticipated projects by the Maharashtra State Infrastructure Development Corporation.

The most recent analyst rating on (AU:EDE) stock is a Hold with a A$0.07 price target. To see the full list of analyst forecasts on Eden Innovations stock, see the AU:EDE Stock Forecast page.

Eden Innovations Plans Convertible Note and Option Issue to Boost Funding

Eden Innovations Ltd has lodged details of a proposed capital raising with the ASX, outlining plans to issue up to 2.2 million convertible notes and 20 million options exercisable at A$0.07 and expiring on 8 September 2027. The proposed placement, scheduled for issue on 13 January 2026, is expected to strengthen the company’s funding position and provide additional financial flexibility, with potential dilution for existing shareholders but also offering scope to support future growth initiatives and operational needs.

The most recent analyst rating on (AU:EDE) stock is a Hold with a A$0.05 price target. To see the full list of analyst forecasts on Eden Innovations stock, see the AU:EDE Stock Forecast page.

Eden Innovations Wipes Out High-Cost Debt with $2.2m Strategic Note

Eden Innovations has secured a $2.2 million strategic convertible note from 7 Enterprises Pty Ltd to eliminate its remaining $2.7 million iBorrow loan, removing a high‑cost debt facility that was costing more than $1 million annually in interest and servicing. By fully repaying the iBorrow facility and replacing it with capitalised‑interest funding secured over a US property, Eden materially strengthens its balance sheet, reduces near‑term refinancing and cash flow risk, and improves the translation of its accelerating revenue growth—particularly in the US, OptiBlend quotations, and EdenCrete sales in Ecuador—into free cash flow, leaving the company better positioned for 2026 with institutional investor backing.

The most recent analyst rating on (AU:EDE) stock is a Hold with a A$0.05 price target. To see the full list of analyst forecasts on Eden Innovations stock, see the AU:EDE Stock Forecast page.

Eden Innovations Director Increases Indirect Stake via Loan Repayment Share Issue

Eden Innovations has disclosed a change in the interests of director Doug Solomon, detailing adjustments to his direct and indirect holdings in the company’s shares and options. The change stems from a partial repayment of an outstanding loan through the issue of 28,571,428 fully paid ordinary shares and 14,285,714 unlisted options at a deemed price of A$0.035 per share, following shareholder approval on 18 December 2025, resulting in a substantial increase in Solomon’s indirect equity and option position and further aligning his interests with those of shareholders.

The most recent analyst rating on (AU:EDE) stock is a Hold with a A$0.05 price target. To see the full list of analyst forecasts on Eden Innovations stock, see the AU:EDE Stock Forecast page.

Eden Innovations Director Boosts Stake Through Loan Repayment Share Issue

Eden Innovations has disclosed a significant change in the holdings of director Gregory Howard Solomon, following a shareholder-approved transaction that partially repaid an outstanding loan via the issue of new equity. Solomon, through his direct and indirect interests including Arkenstone Pty Ltd entities, acquired 28,571,428 fully paid ordinary shares and 14,285,714 unlisted options (exercisable at $0.07, expiring 8 September 2027) at a deemed price of $0.035 per share, increasing his indirect shareholding to 101,759,990 shares and unlisted options at $0.07 to 18,285,714. The transaction strengthens Eden Innovations’ balance sheet by reducing debt while further consolidating Solomon’s position as a key shareholder, underlining a strong alignment between the director’s interests and those of other investors.

The most recent analyst rating on (AU:EDE) stock is a Hold with a A$0.05 price target. To see the full list of analyst forecasts on Eden Innovations stock, see the AU:EDE Stock Forecast page.

Eden Innovations Issues New Shares for Placement and Loan Repayment

Eden Innovations has issued 7,142,857 fully paid ordinary shares to Noble Energy Pty Ltd as the second tranche of an agreed share placement, and a further 57,142,856 fully paid ordinary shares to Arkenstone Pty Ltd and March Bells Pty Ltd, entities associated with directors Greg Solomon and Doug Solomon, in repayment of loans. The company confirmed that these placement and loan repayment shares were issued without the need for a prospectus under the Corporations Act disclosure provisions and that it remains compliant with its financial reporting and continuous disclosure obligations, with no additional undisclosed information required at this time, clarifying the regulatory status of the new equity for existing and new shareholders.

The most recent analyst rating on (AU:EDE) stock is a Hold with a A$0.04 price target. To see the full list of analyst forecasts on Eden Innovations stock, see the AU:EDE Stock Forecast page.

Eden Innovations Issues 3.6 Million Unquoted Options

Eden Innovations has notified the market that it has issued 3,571,428 unquoted options, each exercisable at A$0.07 and expiring on 8 September 2027. The options, which form part of previously announced transactions and are not intended to be quoted on the ASX, modestly expand the company’s pool of equity-linked securities and may provide additional future capital if exercised, with limited immediate impact on existing shareholders given their unquoted status.

The most recent analyst rating on (AU:EDE) stock is a Hold with a A$0.04 price target. To see the full list of analyst forecasts on Eden Innovations stock, see the AU:EDE Stock Forecast page.

Eden Innovations Issues 28.6 Million Unquoted Options Under Existing Transaction

Eden Innovations has notified the market of the issue of 28,571,428 unquoted options, exercisable at $0.07 and expiring on 8 September 2027. The options, which are not intended to be quoted on the ASX, form part of a previously announced transaction and signal a fresh round of equity-linked incentives or funding that may influence the company’s future capital structure and potential shareholder dilution.

The most recent analyst rating on (AU:EDE) stock is a Hold with a A$0.04 price target. To see the full list of analyst forecasts on Eden Innovations stock, see the AU:EDE Stock Forecast page.

Eden Innovations Seeks ASX Quotation for 57.1 Million New Shares

Eden Innovations Ltd has applied for quotation of 57,142,856 new fully paid ordinary shares on the Australian Securities Exchange, with an issue date of 19 December 2025. The enlarged quoted capital base is expected to provide the company with additional flexibility in capital management and may have implications for existing shareholders through dilution and enhanced liquidity in the stock.

The most recent analyst rating on (AU:EDE) stock is a Hold with a A$0.04 price target. To see the full list of analyst forecasts on Eden Innovations stock, see the AU:EDE Stock Forecast page.

Eden Innovations Reports Successful Resolutions at General Meeting

Eden Innovations Ltd announced that all resolutions presented during its General Meeting on December 18, 2025, were successfully passed via polls without amendment. The resolutions dealt with the issuance of securities for debt conversion and other corporate matters, indicating a step forward in the company’s financial and strategic positioning. This marks a positive development, potentially enhancing Eden Innovations’ operational capabilities and strengthening relations with key stakeholders.

The most recent analyst rating on (AU:EDE) stock is a Hold with a A$0.04 price target. To see the full list of analyst forecasts on Eden Innovations stock, see the AU:EDE Stock Forecast page.

Eden Innovations Secures Major Order from Holcim Ecuador for EdenCrete®Pz7

Eden Innovations has secured its largest order to date from Holcim Ecuador for its EdenCrete®Pz7 product, valued at approximately A$514,833. This order signifies a growing demand for Eden’s product, with expectations for annual sales to Holcim Ecuador to reach around US$800,000. The ongoing relationship with Holcim, a major player in the global cement and concrete industry, is crucial for Eden’s strategic goal of achieving positive cash flow by 2026.

The most recent analyst rating on (AU:EDE) stock is a Hold with a A$0.04 price target. To see the full list of analyst forecasts on Eden Innovations stock, see the AU:EDE Stock Forecast page.

Eden Innovations Announces AGM Results and Auditor Change

Eden Innovations Ltd announced that all resolutions were passed at its Annual General Meeting, including the appointment of Stantons International Audit and Consulting Pty Ltd as the new external auditor. This change in auditor, effective immediately, marks a significant shift in the company’s financial oversight. The successful passing of all resolutions, including the approval of the Employee Securities Incentive Plan and a 10% Placement Facility, indicates strong shareholder support and positions the company for future strategic initiatives.

The most recent analyst rating on (AU:EDE) stock is a Hold with a A$0.04 price target. To see the full list of analyst forecasts on Eden Innovations stock, see the AU:EDE Stock Forecast page.

Eden Innovations Highlights Strategic Focus and Market Challenges at AGM

Eden Innovations Limited has released a presentation at their Annual General Meeting, highlighting the company’s strategic focus on enhancing its competitive position in the nanomaterials and fuel reduction sectors. The announcement underscores potential growth opportunities and challenges, including market acceptance, regulatory compliance, and economic conditions, which could impact Eden’s operational results and stakeholder interests.

The most recent analyst rating on (AU:EDE) stock is a Hold with a A$0.04 price target. To see the full list of analyst forecasts on Eden Innovations stock, see the AU:EDE Stock Forecast page.

Eden Innovations Announces General Meeting of Shareholders

Eden Innovations Ltd has announced an upcoming General Meeting of Shareholders scheduled for December 18, 2025, in Perth, Western Australia. The meeting will address key company matters, and shareholders are encouraged to participate either in person or via proxy. The company has made the meeting materials available online, reflecting a commitment to accessibility and transparency. This meeting is significant for stakeholders as it provides an opportunity to engage with the company’s strategic direction and governance.

Eden Innovations Issues New Unquoted Securities

Eden Innovations Ltd announced the issuance of over 20 million unquoted securities, which are set to expire in September 2027. This move is part of previously announced transactions, and it highlights the company’s ongoing efforts to manage its equity and financial strategies effectively, potentially impacting its market positioning and stakeholder interests.

Eden Innovations Issues New Shares to Strengthen Market Position

Eden Innovations Ltd has issued 117,085,716 fully paid ordinary shares to sophisticated and professional investors at $0.035 per share. This issuance, part of a shortfall securities offer, is intended to strengthen the company’s financial position and support its ongoing projects, reflecting a strategic move to bolster its market presence.

Eden Innovations Announces Proposed Securities Issue to Fuel Growth

Eden Innovations Ltd announced a proposed issue of securities, including 57,142,856 ordinary fully paid shares and 28,571,428 options expiring in September 2027. This strategic move is aimed at raising capital to support the company’s ongoing projects and growth initiatives, potentially strengthening its market position and offering new opportunities for stakeholders.

Eden Innovations Issues New Unquoted Securities

Eden Innovations Ltd announced the issuance of 58,542,857 unquoted securities, set to expire in September 2027, as part of a previously announced transaction. This move could potentially enhance the company’s financial flexibility and strategic positioning in its market, impacting stakeholders by possibly increasing the company’s operational capacity and market reach.

Eden Innovations Announces Quotation of New Securities on ASX

Eden Innovations Ltd has announced the application for the quotation of 117,085,716 ordinary fully paid securities on the Australian Securities Exchange (ASX). This move is part of previously announced transactions, indicating a strategic effort to enhance the company’s financial flexibility and market presence.

Eden Innovations Updates Securities Issue Date

Eden Innovations Ltd has announced an update to its previous statement regarding the proposed issue of securities, with the new issue date set for 18 November 2025. This update is part of the company’s strategic financial maneuvers, potentially impacting its market positioning and offering stakeholders insights into its future growth and operational plans.

Eden Innovations Secures $4.35 Million in Capital Raising

Eden Innovations Ltd has successfully secured commitments to raise approximately $4.35 million through a placement of shortfall securities from its recent entitlement offer. This capital will support the marketing and commercialization of its products, EdenCrete® and OptiBlend®, and is part of the company’s financial restructuring efforts, which also included the sale of a property in Georgia to repay debt.

Eden Innovations Completes Georgia Property Sale, Reduces Debt

Eden Innovations Ltd has successfully completed the sale of its Georgia property for US$5 million, significantly reducing its debt. The proceeds were used to repay a substantial portion of the iBorrow loan, decreasing the company’s total debt by approximately 70% to AUD $5.2 million. This financial restructuring, alongside growing sales of its core products, positions Eden for a more stable financial future.